ISS suggest Enhabit shareholders elect three AREX Capital nominees to board
By Svea Herbst-Bayliss
July 11 (Reuters) -Institutional Shareholder Services (ISS) on Thursday said Enhabit EHAB.N shareholders should elect three AREX Capital Management director candidates to the nine member board, arguing the company needs more expertise in home health, hospice and public company financial reporting.
The prominent proxy advisory firm, whose recommendations often guide shareholder votes on proposed mergers and who serves on a board, said AREX made a convincing case that new directors are needed. But the hedge fund did not persuade ISS that a majority of the two-year-old company's directors should be ousted, the report reviewed by Reuters said.
AREX is asking investors to replace seven directors to help reverse poor financial performance. It has also been pushing the home health and hospice provider to put itself up for sale.
Investors will vote on July 25 unless the two sides reach an agreement before the meeting date.
"The company's significant underperformance, both from a TSR (total shareholder return) and operational standpoint, indicate that a degree of change is needed at the board level," ISS wrote. Enhabit's stock price has tumbled nearly 60% since it was spun off of post-acute healthcare services provider Encompass Health EHC.N in July 2022.
ISS recommended votes for AREX candidates Gregory Sheff, who has home health operations experience, Anna-Gene O'Neal, who has hospice experience, and Mark Ohlendorf, who has public company chief financial officer experience.
AREX, which owns a 4.9% stake in Enhabit, is backing Enhabit CEO Barbara Jacobsmeyer and director Barry Schochet for reelection. Schochet joined the board last year when the company reached an agreement with investors Cruiser Capital and Harbour Point Capital Management in March 2023.
AREX told Enhabit last year that it wanted the company to commit to immediately start a strategic review before the end of 2023. Enhabit in May said it decided to continue as an independent, public company after having evaluated a range of strategic options.
A company representative was not immediately available for comment on the ISS recommendation and AREX declined to comment.
Reporting by Svea Herbst-Bayliss; Editing by Christian Schmollinger
免責聲明: XM Group提供線上交易平台的登入和執行服務，允許個人查看和/或使用網站所提供的內容，但不進行任何更改或擴展其服務和訪問權限，並受以下條款與條例約束：（i）條款與條例；（ii）風險提示；（iii）完全免責聲明。網站內部所提供的所有資訊，僅限於一般資訊用途。請注意，我們所有的線上交易平台內容並不構成，也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。
所有缐上交易平台所發佈的資料，僅適用於教育/資訊類用途，不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議，或是交易價格紀錄，或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。
本網站的所有XM和第三方所提供的内容，包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接，皆爲‘按原狀’，並作爲一般市場評論所提供，而非投資建議。請理解和接受，所有被歸類為投資研究範圍的相關内容，並非爲了促進投資研究獨立性，而根據法律要求所編寫，而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊，相關詳情請點擊 這裡查看。
